Details for New Drug Application (NDA): 018588
✉ Email this page to a colleague
NDA 018588 describes NITROSTAT, which is a drug marketed by Parke Davis and Viatris and is included in five NDAs. It is available from eight suppliers. Additional details are available on the NITROSTAT profile page.
The generic ingredient in NITROSTAT is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
The generic ingredient in NITROSTAT is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for 018588
| Tradename: | NITROSTAT |
| Applicant: | Parke Davis |
| Ingredient: | nitroglycerin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018588
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.8MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 5MG/ML | ||||
| Approval Date: | Dec 23, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
